Cholic Acid

CHEMBL205596 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
408.6 g/mol
LogP
3.6
Phase
4

A primary bile acid that facilitates the absorption of dietary fats and fat-soluble vitamins in the small intestine by emulsifying lipid droplets. It is used therapeutically to treat inborn errors of bile acid synthesis, rare metabolic disorders that impair the body's ability to produce bile acids naturally. Oral replacement with cholic acid helps restore normal bile flow and prevents progressive liver damage.

Berat Molekul

408,6000 g/mol

LogP

3,60

TPSA

98,00 Ų

Lipinski RO5

Lulus

Area Terapeutik

Mekanisme Kerja

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

InChI

InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1

Molecular Formula

C24H40O5

HBD / HBA

4 / 5

Ikatan yang Dapat Dirotasi

4

Atom Berat

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A primary bile acid that facilitates the absorption of dietary fats and fat-soluble vitamins in the small intestine by emulsifying lipid droplets. It is used therapeutically to treat inborn errors of bile acid synthesis, rare metabolic disorders that impair the body's ability to produce bile acids naturally. Oral replacement with cholic acid helps restore normal bile flow and prevents progressive liver damage.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Cholic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL205596. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 221493. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.